Chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxin of
Staphylococcus aureus Staphylococcus aureus Staphylococcus aureus 32Staphylococcus aureus. The invention relates to a chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxins of and a use thereof. The chemosynthetic peptide can specifically inhibit production of the toxins of by mean...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Staphylococcus aureus Staphylococcus aureus Staphylococcus aureus 32Staphylococcus aureus. The invention relates to a chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxins of and a use thereof. The chemosynthetic peptide can specifically inhibit production of the toxins of by means of the binding of the RNAIII activator protein by a autocrine. The invention also relates to the use of the chemosynthetic peptide in the pharmaceutical field. The sequence general formula of the chemosynthetic cyclo-hepta modified peptide is CH-(CH)m-X-G-(CQHWWHWYC)-(R)n-Y. The results show that the modified peptide can be dissolved well in water and has good activity against the toxins of |
---|